ArticleRMD open2019

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.

Huifang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.